authors
-
Paweł Szymanowski, Zbigniew Kwias, Piotr Nowakowski
- Z Katedry i Kliniki Urologii Akademii Medycznej im. K. Marcinkowskiego w Poznaniu
Kierownik Katedry i Kliniki: prof. dr hab. med. Zbigniew Kwias
keywords
-
urinary bladder carcinoma isoantigens A, B, H
summary
- The expression of the blood group isoantigens ABH in 97 patients with yarious
- stages of bladder cancer was analysed. 32% of ABH positiveand 83% of ABH negative
- patients died during 3-years observation. In the group of 30 patients with superficial
- bladder cancer (pTa-1) recurrences and progression were analysed. 19% of recurrents
- and 5% of progression was found in ABH positive patients. In the ABH negative
- patients 67% recurrents and 78% progression occurred.
references
- (1) Abel P. D., Thorpe S. J., Wiliams G.: Blood group antigen in frozen section of
- present-ing bladder cancer: 3-year prospetive follow-up of Prognostic value. Br. J.
- Urol., 1989,63, 171-175.
- (2) Baranyay F, Knels /?., Somogyi L.: The distribution of ABO(H) isoantigens in uri-
- nary bladder tumours. Acta. Med. Hung., 1992, 49, 129-136.
- (3) Borgstrom E., Gustafson //.: ABH isoantigens in bladder carcinoma patients grouped
- according to DNA changes over time. Scand. J. Urol. Nephrol., 1987, 21, 125-130.
- (4) Coon J. S., Weinstein R. S.: Blood group-related antigens as markers of malignant
- potential and heterogeneity in human carcinomas. Hum. Path., 1986, 17, 1089.
- (5) Cuadrado E., Rodriguez-Trinidad A., Blasco E., TorradoJ., GarciaJ. A. L., Aroze-
- na F.: Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a
- clinicopathological study. J. Urol., 1986, 135, 409-415.
- (6) Decennzo J.M., Howard P, lrish C.E.: Antigenic deletion and prognosis of patients
- with stage A transitional cell bladder carcinoma. J. Urol, 1975, 114, 874-878.
- (7) Fukatsu H, Nonomura H., Miyagawa Y, Waki M., Hatano Y, Hiraiwa S., Mura-
- matsu T, Tukamura T, Yamada X, Nishikawa E:. The study of the ABH isoantigen
- of bladder tumors. Hinyokika-Kiyo 1987, 33, 857-863.
- (8) Ile¶ R. K., Chard T:. Human gonadotropin expression by bladder cancers: biology
- and clinical potential. J. Urol., 1991, 145, 453-458.
- (9) Limas C, Lange P.: T-antigen in normal and neoplastic urothelium. Cancer, 1986,
- 58, 1236-1245.
-
- (10) Limas C, Lange P.: Lewis antigens in normal and neoplastic urothelium. Am. J.
- Pathol.1985, 121, 176-183.
- (11) Limas C, Lange P., Fraley E. E., Yassella R. L:. A, B, H antigens in transitional cell
- tumors of the urinary bladder: correlation with clinical course. Cancer, 1979, 44,
- 2099-2107.
- (12) Malmstrom P. U., Busch C, Norlen B. J., Andersson B.: Expression of ABH group
- isoantigen as a Prognostic factor in transitional cell bladder carcinoma. Scand. J.
- Urol. Nephrol., 1988, 22, 265-270.
- (13) Newman A. J. Jr., Carlton C. E., Johnson S.: Cell surface A, B or O(H) blood group
- antigens as an indicator of malignant in stage A bladder carcinoma. J. Urol., 1980,
- 124,27-29.
- (14) Orihuela E., Varadachay S., Herr H. W., MelamedM. R., Whitmore W. F.: Theprac-
- tical use of tumor marker determination in bladder washing specimens. Cancer, 1987,
- 60, 1009-1016.
- (15) Sheinfeld J., Reuter V., Fair W. R., Cordon C: Expression of blood group antigens
- in bladder cancer: current concepts. Semin. Surg. Oncol., 1992, 8(5) 308-315.
- (16) Tan L. B., Chiang C, Huang C. H., Lin L. M:. Detection of blood group surface
- antigens of urinary bladder tumours using monoclonal antibodies with avidin-bio-
- tin complex techni±ue. Int. Urol. Nephrol., 1992, 24, 255-264.
- (17) Zieliński J.: Nowotwory pęcherza moczowego. W: Urologia, Tom II, pod red. J.
- Zielińskiego i J. Leńki. PZWL, Warszawa 1993, 407-439.
|